Amphipathic small molecules mimic the binding mode and function of endogenous transcription factors.

Small molecules that reconstitute the binding mode(s) of a protein and in doing so elicit a programmed functional response offer considerable advantages in the control of complex biological processes. The development challenges of such molecules are significant, however. Many protein-protein interactions require multiple points of contact over relatively large surface areas. More significantly, several binding modes can be superimposed upon a single sequence within a protein, and a true small molecule replacement must be preprogrammed for such multimodal binding. This is the case for the transcriptional activation domain or TAD of transcriptional activators as these motifs utilize a poorly characterized multipartner binding profile in order to stimulate gene expression. Here we describe a unique class of small molecules that exhibit both function and a binding profile analogous to natural transcriptional activation domains. Of particular note, the small molecules are the first reported to bind to the KIX domain within the CREB binding protein (CBP) at a site that is utilized by natural activators. Further, a comparison of functional and nonfunctional small molecules indicates that an interaction with CBP is a key contributor to transcriptional activity. Taken together, the evidence suggests that the small molecule TADs mimic both the function and mechanism of their natural counterparts and thus present a framework for the broader development of small molecule transcriptional switches.

[1]  A. Mapp,et al.  Expanding the repertoire of small molecule transcriptional activation domains. , 2009, Bioorganic & medicinal chemistry.

[2]  Chinmay Y. Majmudar,et al.  Mocr: a novel fusion tag for enhancing solubility that is compatible with structural biology applications. , 2009, Protein expression and purification.

[3]  J. Omichinski,et al.  NMR structure of the complex between the Tfb1 subunit of TFIIH and the activation domain of VP16: structural similarities between VP16 and p53. , 2008, Journal of the American Chemical Society.

[4]  A. Mapp,et al.  Assessing the permissiveness of transcriptional activator binding sites. , 2008, Biopolymers.

[5]  K. Struhl,et al.  A nuclear receptor-like pathway regulating multidrug resistance in fungi , 2008, Nature.

[6]  N. Sharma,et al.  The Human T-Cell Leukemia Virus Type 1 Tax Protein Confers CBP/p300 Recruitment and Transcriptional Activation Properties to Phosphorylated CREB , 2007, Molecular and Cellular Biology.

[7]  J. Nyborg,et al.  Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300. , 2007, Journal of molecular biology.

[8]  A. Mapp,et al.  Transcriptional up-regulation in cells mediated by a small molecule. , 2007, Journal of the American Chemical Society.

[9]  T. Kodadek,et al.  Design and synthesis of a cell-permeable synthetic transcription factor mimic. , 2007, Journal of combinatorial chemistry.

[10]  A. Ansari,et al.  A TAD further: exogenous control of gene activation. , 2007, ACS chemical biology.

[11]  Bo Liu,et al.  Isolation and characterization of coactivator-binding peptoids from a combinatorial library. , 2006, Molecular bioSystems.

[12]  M. Carey,et al.  A mechanism for coordinating chromatin modification and preinitiation complex assembly. , 2006, Molecular cell.

[13]  John S. Satterlee,et al.  An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis , 2006, Nature.

[14]  Hans‐Dieter Arndt Small molecule modulators of transcription. , 2006, Angewandte Chemie.

[15]  R. Tjian,et al.  Coactivator cross-talk specifies transcriptional output. , 2006, Genes & development.

[16]  Lawryn H Kasper,et al.  Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development , 2006, Molecular and Cellular Biology.

[17]  Peter E Wright,et al.  Structural Basis for Cooperative Transcription Factor Binding to the CBP Coactivator , 2005, Journal of molecular biology.

[18]  Steven Hahn,et al.  Targets of the Gal4 Transcription Activator in Functional Transcription Complexes , 2005, Molecular and Cellular Biology.

[19]  A. Mapp,et al.  Stereochemical promiscuity in artificial transcriptional activators. , 2005, Journal of the American Chemical Society.

[20]  T. Kodadek,et al.  A potent transactivation domain mimic with activity in living cells. , 2005, Journal of the American Chemical Society.

[21]  Jerry L. Workman,et al.  Mechanism of Transcription Factor Recruitment by Acidic Activators* , 2005, Journal of Biological Chemistry.

[22]  S. Hahn,et al.  Function of a eukaryotic transcription activator during the transcription cycle. , 2005, Molecular cell.

[23]  R. Roeder,et al.  Structural and Functional Characterization of PC2 and RNA Polymerase II-Associated Subpopulations of Metazoan Mediator , 2005, Molecular and Cellular Biology.

[24]  R. Roeder,et al.  Transcriptional regulation and the role of diverse coactivators in animal cells , 2005, FEBS letters.

[25]  Rob Kaptein,et al.  Structural properties of the promiscuous VP16 activation domain. , 2005, Biochemistry.

[26]  K. Gardner,et al.  Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Mapp,et al.  A small molecule transcriptional activation domain. , 2004, Journal of the American Chemical Society.

[28]  Peter E Wright,et al.  Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. , 2004, Journal of molecular biology.

[29]  Michael R Green,et al.  In vivo target of a transcriptional activator revealed by fluorescence resonance energy transfer. , 2004, Genes & development.

[30]  Frank Eisenhaber,et al.  Linking transcriptional mediators via the GACKIX domain super family , 2004, Current Biology.

[31]  K. Lumb,et al.  NMR mapping of the HIV-1 Tat interaction surface of the KIX domain of the human coactivator CBP. , 2004, Biochemistry.

[32]  Thomas Kodadek,et al.  Isolation of protein ligands from large peptoid libraries. , 2003, Journal of the American Chemical Society.

[33]  Chinmay Y. Majmudar,et al.  Targeting the transcriptional machinery with unique artificial transcriptional activators. , 2003, Journal of the American Chemical Society.

[34]  K. Lumb,et al.  KIX-mediated assembly of the CBP-CREB-HTLV-1 tax coactivator-activator complex. , 2003, Biochemistry.

[35]  K. Lumb,et al.  Molecular recognition of the human coactivator CBP by the HIV-1 transcriptional activator Tat. , 2003, Biochemistry.

[36]  P. Chène Inhibiting the p53–MDM2 interaction: an important target for cancer therapy , 2003, Nature Reviews Cancer.

[37]  Amelia A. Fuller,et al.  A concise approach to structurally diverse beta-amino acids. , 2003, Journal of the American Chemical Society.

[38]  A. Ansari,et al.  Modular design of artificial transcription factors. , 2002, Current opinion in chemical biology.

[39]  K. Lumb,et al.  Structurally distinct modes of recognition of the KIX domain of CBP by Jun and CREB. , 2002, Biochemistry.

[40]  Peter E Wright,et al.  Cooperativity in Transcription Factor Binding to the Coactivator CREB-binding Protein (CBP) , 2002, The Journal of Biological Chemistry.

[41]  Peter E Wright,et al.  Roles of Phosphorylation and Helix Propensity in the Binding of the KIX Domain of CREB-binding Protein by Constitutive (c-Myb) and Inducible (CREB) Activators* , 2002, The Journal of Biological Chemistry.

[42]  J. Darnell Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.

[43]  J. Qin,et al.  External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Lisa E. Gralinski,et al.  Transcriptional Regulation of the mdm2 Oncogene by p53 Requires TRRAP Acetyltransferase Complexes , 2002, Molecular and Cellular Biology.

[45]  D. Botstein,et al.  Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.

[46]  Thomas Kodadek,et al.  Recruitment of a 19S Proteasome Subcomplex to an Activated Promoter , 2002, Science.

[47]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[48]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[49]  J. Manfredi,et al.  Multiple roles of the tumor suppressor p53 , 2002, Current opinion in oncology.

[50]  T. Kodadek,et al.  The Gal4 Activation Domain Binds Sug2 Protein, a Proteasome Component, in Vivo and in Vitro * , 2001, The Journal of Biological Chemistry.

[51]  A. Ansari Regulating Gene Expression: The Design of Synthetic Transcriptional Regulators , 2001 .

[52]  C. J. Jeong,et al.  Evidence that Gal11 protein is a target of the Gal4 activation domain in the mediator. , 2001, Biochemistry.

[53]  N. L. La Thangue,et al.  p300/CBP proteins: HATs for transcriptional bridges and scaffolds. , 2001, Journal of cell science.

[54]  J. Workman,et al.  Recruitment of HAT Complexes by Direct Activator Interactions with the ATM-Related Tra1 Subunit , 2001, Science.

[55]  E. Carreira,et al.  A General Solution to the Modular Synthesis of Polyketide Building Blocks by Kanemasa Hydroxy-Directed Nitrile Oxide Cycloadditions. , 2001, Angewandte Chemie.

[56]  S. Korsmeyer,et al.  MLL and CREB Bind Cooperatively to the Nuclear Coactivator CREB-Binding Protein , 2001, Molecular and Cellular Biology.

[57]  P. Pandolfi Transcription therapy for cancer , 2001, Oncogene.

[58]  Dimitris Thanos,et al.  Ordered Recruitment of Chromatin Modifying and General Transcription Factors to the IFN-β Promoter , 2000, Cell.

[59]  L. Cantley,et al.  Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening , 2000, Nature Biotechnology.

[60]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[61]  R. Goodman,et al.  CBP/p300 in cell growth, transformation, and development. , 2000, Genes & development.

[62]  S. Ishii,et al.  Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein , 2000, Mechanisms of Development.

[63]  R. Roeder,et al.  Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells. , 2000, Trends in biochemical sciences.

[64]  H. Dyson,et al.  Structural analyses of CREB-CBP transcriptional activator-coactivator complexes by NMR spectroscopy: implications for mapping the boundaries of structural domains. , 1999, Journal of molecular biology.

[65]  M. Uesugi,et al.  The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[66]  M. Yaffe,et al.  Analysis of an activator:coactivator complex reveals an essential role for secondary structure in transcriptional activation. , 1998, Molecular cell.

[67]  T. Kodadek,et al.  Small-molecule-based strategies for controlling gene expression. , 1998, Chemistry & biology.

[68]  Medeva Ghee,et al.  AP-1, CREB and CBP transcription factors differentially regulate the tyrosine hydroxylase gene. , 1998, Brain research. Molecular brain research.

[69]  Peter E Wright,et al.  Solution Structure of the KIX Domain of CBP Bound to the Transactivation Domain of CREB: A Model for Activator:Coactivator Interactions , 1997, Cell.

[70]  H. Masuya,et al.  Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[71]  A. Levine,et al.  Induced alpha helix in the VP16 activation domain upon binding to a human TAF. , 1997, Science.

[72]  Raoul C. M. Hennekam,et al.  Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.

[73]  G. Prestwich,et al.  Benzophenone photophores in biochemistry. , 1994, Biochemistry.

[74]  A. Kamimura,et al.  First Successful Metal Coordination Control in 1,3-Dipolar Cycloadditions. High-Rate Acceleration and Regio- and Stereocontrol of Nitrile Oxide Cycloadditions to the Magnesium Alkoxides of Allylic and Homoallylic Alcohols , 1994 .

[75]  Masatoshi Hagiwara,et al.  Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.

[76]  S. Johnston,et al.  Genetic evidence that an activation domain of GAL4 does not require acidity and may form a β sheet , 1993, Cell.

[77]  T. Kodadek,et al.  The acidic activation domains of the GCN4 and GAL4 proteins are not alpha helical but form beta sheets. , 1993, Cell.